Johnson & Johnson Innovation - JJDC Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 12
Professionals
  • Investments
  • 363
  • Portfolio
  • 99
  • Exits
  • 152
Exits

Johnson & Johnson Innovation - JJDC General Information

Description

Founded in 1973, Johnson & Johnson Innovation-JJDC is the corporate venture capital arm of Johnson & Johnson based in New Brunswick, New Jersey. The firm prefers to make investments in pharmaceuticals, medical devices, and consumer healthcare sectors.

Contact Information

Formerly Known As
Johnson & Johnson Development Corporation
Year Founded
1973
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 410 George Street
  • New Brunswick, NJ 08901
  • United States
+1 (732) 000-0000

Johnson & Johnson Innovation - JJDC Investments (363)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Paige 14-Jan-2021 Later Stage VC 00000 Laboratory Services (Healthcare) Generating Revenue
000 00000000000000 05-Jan-2021 00000 00000 0000 Biotechnology Product Development
000 000000000000 22-Dec-2020 00000 00000 000.00 Biotechnology Generating Revenue
0000000 09-Nov-2020 00000 00000 00.000 Personal Products Generating Revenue
0-0000 22-Sep-2020 00000 00000 0000 Therapeutic Devices Clinical Trials - General
00 000000000000 18-Sep-2020 00000 00000 0000 Drug Discovery Pre-Clinical Trials
000000 000 14-Sep-2020 00000 00000 0000 Biotechnology Clinical Trials - Phase 1 00000 000000 00.0
000000 26-Aug-2020 00000 00000 0000 Decision/Risk Analysis Generating Revenue
GI Windows 19-Aug-2020 Later Stage VC 000.00 Surgical Devices Generating Revenue 0.00000 0000000000 00.0
ImmPACT-Bio 18-Aug-2020 Early Stage VC 0000 Biotechnology Generating Revenue
You’re viewing 10 of 363 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Johnson & Johnson Innovation - JJDC Exits (149)

Company Name Exit Date Exit Type Exit Size
Fusion Pharmaceuticals 26-Jun-2020 IPO 00000
0000000 12-Jun-2020 000 00000
000000 0000000 05-Jun-2020 000 00000
00000000 02-Jun-2020 0000000000: 000000
00000 000000 14-May-2020 000000000000000000
000000 06-Apr-2020 0000000000: 000000
000000 0000000 24-Jan-2020 000000000000000000 00000
00000000 15-Jan-2020 000000000000000000 0000
Rodin Therapeutics 25-Nov-2019 Merger/Acquisition 00000
NeuroSearch 07-Oct-2019 Merger/Acquisition
You’re viewing 10 of 149 exits. Get the full list »

Johnson & Johnson Innovation - JJDC Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Johnson & Johnson Innovation - JJDC Team (45)

Name Title Deals Funds Boards Office
Chris Picariello President New Brunswick, NJ
Claire Leurent Ph.D Principal, Venture Investments Boston, MA
Anurag Mehta Principal, Venure Investments New York, NY
Dan Wang Head New Brunswick, NJ
Michal Preminger Ph.D Head 0 New Brunswick, NJ
You’re viewing 5 of 45 team members. Get the full list »

Johnson & Johnson Innovation - JJDC Co-Investors (340)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 6 0 Series chart Industry bar
Novartis Venture Fund 0 0 Series chart Industry bar
OrbiMed 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 Series chart Industry bar
Osage University Partners 0 0 Series chart Industry bar
You’re viewing 5 of 340 co-investors. Get the full list »